SCNI

#5254
Scinai Immunotherapeutics Ltd. American Depositary Shares
0.5550 USD
-7.50%
Setor: Cuidados de saúde
Base: USD
Moeda do lucro: USD
Faixa diária
0.5550
0.5550
Faixa anual
0.5500
1.0499
Mudança diária
-7.50%
Mudança mensal
-25.00%
Mudança em 6 meses
-26.61%
Mudança anual
-26.61%
Fechamento anterior
0.6000
Abrir
0.5550
Bid
Ask
Mínimo
0.5550
High
0.5550
Volume
1
Abrir gráfico completo

Financials

Visão geral Relatórios Estatísticas
Trimestral Ano
  • Market Capitalization 1.9249 M
  • Employee 45
  • Founded 2003
  • CEO N/A
  • Website www.scinai.com
  • Headquarter Israel
  • FIGI BBG007TGL1R2
  • Industry Biotecnologia
Receita total
Lucro líquido
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa

Scinai Immunotherapeutics Ltd - American Depositary Shares

BiondVax Pharmaceuticals Ltd. is an Israeli biopharmaceutical company focused on developing and manufacturing immunotherapeutic products, primarily for the treatment of infectious diseases and autoimmune diseases. In collaboration with the Max Planck Institute for Multidisciplinary Sciences and the University Medical Center Göttingen, both in Germany, BiondVax develops nanosized antibody therapies for diseases such as COVID-19, asthma and psoriasis.

Notícias